NGM BIOPHARMACEUTICALS INC Total Assets
NGM BIOPHARMACEUTICALS INC had Total Assets of $168.87 million as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2024-03-11
- 2023-12-31: Assets $168.87M.
- 2023-09-30: Assets $192.15M.
- 2023-06-30: Assets $220.54M.
- 2023-03-31: Assets $258.84M.
| Period end | Assets |
|---|---|
| 2023-12-31 | $168.87M 10-K · filed 2024-03-11 |
| 2023-09-30 | $192.15M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $220.54M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $258.84M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $307.40M 10-K · filed 2024-03-11 |
| 2022-09-30 | $335.87M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $337.37M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $359.77M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $402.39M 10-K · filed 2023-02-28 |
| 2021-09-30 | $415.86M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $423.01M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $445.54M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $329.04M 10-K · filed 2022-03-01 |
| 2020-09-30 | $326.08M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $347.28M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $360.70M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $380.40M 10-K · filed 2021-03-15 |
| 2019-09-30 | $390.62M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $396.70M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $231.63M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $246.09M 10-K · filed 2020-03-17 |